Skip to main content
Top

Infectious Diseases and Therapy

Issue 2/2013

Content (14 Articles)

Open Access Letter from the Editor

Letter from the Editor

Michael J. Rybak

Open Access Review

Integrase Strand Transfer Inhibitors in HIV Therapy

Thibault Mesplède, Mark A. Wainberg

Open Access Review

Ceftaroline Fosamil: A Brief Clinical Review

Debbie-Ann T. Shirley, Emily L. Heil, J. Kristie Johnson

Open Access Review

Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors

Bavithra Nathan, Jake Bayley, Laura Waters, Frank A. Post

Open Access Review

The Problems with Polio: Toward Eradication

Gemma Lien, David L. Heymann

Open Access Original Research

Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity

Molly E. Steed, Ashley D. Hall, Hossein Salimnia, Glenn W. Kaatz, Keith S. Kaye, Michael J. Rybak

Open Access Original Research

Comparative Incidence of Nephrotoxicity by Age Group among Adult Patients Receiving Vancomycin

Joseph J. Carreno, Anthony Jaworski, Rachel M. Kenney, Susan L. Davis

Open Access Original Research

Stable Susceptibility to Aminoglycosides in an Age of Low Level, Institutional Use

John A. Bosso, Martha L. Haines, Juanmanuel Gomez

Open Access Original Research

Amikacin Pharmacokinetics During Continuous Veno-Venous Hemodialysis

Simon W. Lam, Seth R. Bauer

Open Access Publisher's Erratum

Erratum to: Low Specificity of a Malaria Rapid Diagnostic Test During an Integrated Community Case Management Trial

Alfred B. Tiono, Amidou Diarra, Souleymane Sanon, Issa Nébié, Amadou T. Konaté, Franco Pagnoni, Sodiomon B. Sirima

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine